Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Bulletin Du Cancer
|
January 1, 2019
Sabrina Falkowski
Therapeutic Drug Monitoring
|
March 27, 2019
Therapeutic Drug Monitoring of Everolimus in Oncology: Evidences and Perspectives
Sabrina Falkowski, Jean-Baptiste Woillard
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 10, 2009
Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies
Sabrina Falkowski, Patrick Trouillas, Jean-Luc Duroux, et al.
The Gulf Journal of Oncology
|
April 3, 2018
Vaginal metastasis of renal clear-cell cancer
Amel Rehailia-Blanchard, Adekube Morel, Chloé Rancoul, et al.
The Pharmacogenomics Journal
|
February 5, 2020
Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients
Stéphanie Bonnet, Sabrina Falkowski, Marine Deppenweiler, et al.
Pharmacological Research
|
May 6, 2017
Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship
Marine Deppenweiler, Sabrina Falkowski, Franck Saint-Marcoux, et al.
BMC Cancer
|
December 29, 2017
Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study
Sabrina Falkowski, Jean-Baptiste Woillard, Deborah Postil, et al.
Cancers
|
November 13, 2021
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, et al.
Bulletin Du Cancer
|
November 13, 2017
[Crossed perceptions about malnutrition in patients and their doctors in oncology]
Bruno Raynard, Xavier Hébuterne, François Goldwasser, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 19, 2016
Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma-Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study
Stéphane Oudard, Lionnel Geoffrois, Aline Guillot, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Bulletin Du Cancer
|
January 1, 2019
Sabrina Falkowski
Therapeutic Drug Monitoring
|
March 27, 2019
Therapeutic Drug Monitoring of Everolimus in Oncology: Evidences and Perspectives
Sabrina Falkowski, Jean-Baptiste Woillard
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 10, 2009
Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies
Sabrina Falkowski, Patrick Trouillas, Jean-Luc Duroux, et al.
The Gulf Journal of Oncology
|
April 3, 2018
Vaginal metastasis of renal clear-cell cancer
Amel Rehailia-Blanchard, Adekube Morel, Chloé Rancoul, et al.
The Pharmacogenomics Journal
|
February 5, 2020
Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients
Stéphanie Bonnet, Sabrina Falkowski, Marine Deppenweiler, et al.
Pharmacological Research
|
May 6, 2017
Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship
Marine Deppenweiler, Sabrina Falkowski, Franck Saint-Marcoux, et al.
BMC Cancer
|
December 29, 2017
Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study
Sabrina Falkowski, Jean-Baptiste Woillard, Deborah Postil, et al.
Cancers
|
November 13, 2021
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, et al.
Bulletin Du Cancer
|
November 13, 2017
[Crossed perceptions about malnutrition in patients and their doctors in oncology]
Bruno Raynard, Xavier Hébuterne, François Goldwasser, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 19, 2016
Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma-Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study
Stéphane Oudard, Lionnel Geoffrois, Aline Guillot, et al.
Page
of 2